Journal article
Characterization of blue light irradiation effects on pathogenic and nonpathogenic Escherichia coli
MicrobiologyOpen (Weinheim), Vol.6(4), e466
08/2017
DOI: 10.1002/mbo3.466
PMCID: PMC5552948
PMID: 28332311
Abstract
Blue light irradiation (BLI) is an FDA-approved method for treating certain types of infections, like acne, and is becoming increasingly attractive as an antimicrobial strategy as the prevalence of antibiotic-resistant "superbugs" rises. However, no study has delineated the effectiveness of BLI throughout different bacterial growth phases, especially in more BLI-tolerant organisms such as Escherichia coli. While the vast majority of E. coli strains are nonpathogenic, several E. coli pathotypes exist that cause infection within and outside the gastrointestinal tract. Here, we compared the response of E. coli strains from five phylogenetic groups to BLI with a 455 nm wavelength (BLI
), using colony-forming unit and ATP measurement assays. Our results revealed that BLI
is not bactericidal, but can retard E. coli growth in a manner that is dependent on culture age and strain background. This observation is critical, given that bacteria on and within mammalian hosts are found in different phases of growth.
Details
- Title: Subtitle
- Characterization of blue light irradiation effects on pathogenic and nonpathogenic Escherichia coli
- Creators
- Courtney M Abana - Department of Chemical & Biomolecular Engineering, Vanderbilt University, Nashville, TN, USAJohn R Brannon - Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USARebecca A Ebbott - Department of Biological Sciences, Vanderbilt University, Nashville, TN, USATaryn L Dunigan - Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USAKirsten R Guckes - Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USAHubaida Fuseini - Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USAJennifer Powers - Vanderbilt Dermatology, Vanderbilt University Medical Center, Nashville, TN, USABridget R Rogers - Department of Chemical & Biomolecular Engineering, Vanderbilt University, Nashville, TN, USAMaria Hadjifrangiskou - Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA
- Resource Type
- Journal article
- Publication Details
- MicrobiologyOpen (Weinheim), Vol.6(4), e466
- DOI
- 10.1002/mbo3.466
- PMID
- 28332311
- PMCID
- PMC5552948
- NLM abbreviation
- Microbiologyopen
- ISSN
- 2045-8827
- eISSN
- 2045-8827
- Publisher
- England
- Grant note
- UL1 TR000445 / NCATS NIH HHS R25 GM062459 / NIGMS NIH HHS
- Language
- English
- Date published
- 08/2017
- Academic Unit
- Dermatology
- Record Identifier
- 9984025309202771
Metrics
14 Record Views